Aberrant CD20 expression in angioimmunoblastic T-cell lymphoma

Internal Medicine

Volumn 50, Issue 5, 2011, Pages 495-499

  Tachibana, Takayoshi ^a,b   Tomita, Naoto ^a   Furuya, Mitsuko ^a   Yamanaka, Shoji ^a   Takeuchi, Kengo ^c   Nakamura, Naoya ^d   Fujita, Hiroyuki ^a   Ishigatsubo, Yoshiaki ^a  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KANAGAWA CANCER CENTER   (Japan)

^c CANCER INSTITUTE   (Japan)

^d TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angioimmunoblastic T cell lymphoma; CD20; EBER in situ hybridization; Flowcytometry; Immunohistochemical staining; Rituximab

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; METHOTREXATE; METHYLPREDNISOLONE; PIRARUBICIN; PREDNISOLONE; VINCRISTINE;

ADULT; ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; ANOREXIA; ANTIGEN EXPRESSION; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; AUTOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; CD3+ CD20- T LYMPHOCYTE; COLONOSCOPY; COUGHING; EPSTEIN BARR VIRUS; FATIGUE; FLOW CYTOMETRY; HEMORRHAGIC COLITIS; HEMORRHAGIC CYSTITIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; LARGE CELL LYMPHOMA; LYMPH NODE BIOPSY; LYMPHADENOPATHY; LYMPHOMA CELL; MALE; MULTIPLE CYCLE TREATMENT; PEPTIC ULCER BLEEDING; PNEUMONIA; T CELL LYMPHOMA; T LYMPHOCYTE;

ANTIGENS, CD20; ANTIGENS, CD3; EPSTEIN-BARR VIRUS INFECTIONS; FATAL OUTCOME; HUMANS; IMMUNOBLASTIC LYMPHADENOPATHY; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, T-CELL, PERIPHERAL; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY;

EID: 79952328009     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.4386     Document Type: Article

References (17)

1. Alizadeh AA, Advani RH. Evaluation and management of angioimmunoblastic T-cell lymphoma: a review of current approaches and future strategy. Clin Adv in Hematol & Oncol 6: 899-909, 2008.
2. Mourad N, Mounier N, Brière J, et al; Groupe d'Etude des Lymphomes de l' Adulte. Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials. Blood 111: 4463-4470, 2008.
3. Tan BT, Warnke RA, Arber DA. The frequency of B-and T-cell gene rearrangements and Epstein-Barr virus in T-cell lymphomas: a comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified with and without B-cell proliferations. J Mol Diagn 8: 466-475, 2006.
4. Went P, Agostinelli C, Gallamini A, et al. Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. J Clin Oncol 24: 2472-2479, 2006.
5. Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, International Agency for Research on Cancer 309-311, 2008.
6. Miyazaki K, Ohsaka M, Suzuki Y, Danbara M, Horie R, Higashihara M. CD20-positive T-cell large granular lymphocyte leukemia: case report and review of the literature. Intern Med 48: 1443-1447, 2009.
7. Suyama T, Furuya M, Nishiyama M, et al. Up-regulation of interfero gamma (IFN-γ)-inducible chemokines INF-inducible T-cell alpha chemoattractant and monokine induced by INF-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma. Cancer 103: 258-267, 2005.
8. Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346: 235-242, 2002.
9. Xu Y, Mckenna RW, Hoang MP, Collins RH, Kroft SH. Composite angioimmunoblastic T-cell lymphoma and diffuse large B-cell lymphoma: a case report and review of literature. Am J Clin Pathol 118: 848-854, 2002.
10. Hawley RC, Cankovic M, Zarbo RJ. Angioimmunoblastic T-cell lymphoma with supervening Epstein-Barr virus-associated large Bcell lymphoma. Arch Pathol Lab Med 130: 1707-1711, 2006.
11. Attygalle AD, Kyriakou C, Dupuis J, et al. Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies; clinical correlation and insights into natural history and disease progression. Am J Surg Pathol 118: 1077-1088, 2007.
12. Carbone A, Gloghini A, Dotti G. EBV-associated lymphoproliferative disorders: classification and treatment. Oncologist 13: 577-585, 2008.
13. Battegay M, Berger C, Rochlitz C, et al. Epstein-Barr virus load correlating with clinical manifestation and treatment response in a patient with angioimmunoblastic T-cell lymphoma. Antiviral Ther 9: 453-459, 2004.
14. Skugor ND, Perić Z, Vrhovac R, Radić-Kristo D, Kardum-Skelin I, Jaksić B. Diffuse large B-cell lymphoma in patient after treatment of angioimmunoblastic T-cell lymphoma. Coll Antropol 1: 241-245, 2010.
15. Sun T, Akalin A, Rodacker M, Braun T. CD20 positive T cell lymphoma: is it a real entitiy? J Clin Pathol 57: 442-444, 2004.
16. + T-cell lymphoma: clinicopathologic analysis of 9 cases and a review of the literature. Am J Surg Pathol 32: 1593-1607, 2008.
17. Joly B, Frenkel V, Gaulard P, et al. Rituximab in combination with CHOP regimen in angioimmunoblastic T-cell lymphoma (AITL). Preliminary results in 9 patients treated in a single institution. Blood 106: 2686, 2005.